KOFST has been selecting and announcing the 'Top 10 Science and Technology News' annually since 2005 to raise public interest ...

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...

Intestinal stem cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Ipsen has added a Chinese-developed antibody drug conjugate (ADC) to its pipeline in a deal that could top $1bn, cementing ...

With Abivax now trading as a strategic asset rather than a pure clinical story, takeover interest from a deep-pocketed pharma ...

Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) by inhibiting semaphorin 4D (SEMA4D) induced pathology in brain, ...

Specifically, the team confirmed that increased expression of cytoskeleton-binding and actin-binding proteins leads to a stable restructuring of the internal cellular architecture. This provides the ...

Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...

Better Business Advice is recognizing TruDiagnostic in its 2026 assessment of Horvath Clock testing solutions. This mirrors a surge in interest in biological age evaluation as epigenetic tools ...

Detailed price information for Stoke Therapeutics Inc (STOK-Q) from The Globe and Mail including charting and trades.